Discontinuing voriconazole induced no completely regression of multiple cutaneous squamous cell carcinoma in a hematopoietic stem cell transplant patient

Yuka Hirakawa, Aika Okuno, Atsuko Tanabe, Mutsumi Okada, Naoyuki Anzai, Yuki Yamamoto, Fukumi Furukawa

Abstract


Voriconazole is a universal anti-fungal prophylaxis, which is frequently taken to the patients after hematopoietic stem cell transplantation and solid organ transplantation. Voriconazole can cause phototoxicity, multiple erythema in sun-exposed areas may develop actinic keratosis and cutaneous squamous cell carcinoma (cSCC) while taking voriconazole. In North America and Europe, case reports of phototoxicity and aggressive cSCC in patients on voriconazole have been documented. Also 4 cases of voriconazole-associated cSCC have recently been reported in Japan. We describe a Japanese woman with multiple cSCC associated with recurrence of cSCC after discontinuing voriconazole. 


Keywords


Multiple cutaneous squamous cell carcinoma; voriconazole; hematopoietic stem cell transplantation; reccurence; sun-exposed areas

Full Text:

PDF

References


: McCarthy KL, Playford EG, Looke DFM,et al. Severevphotosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis. 2007; 44: e55-56. Doi:10.1086/511685

: Vanacker A, Fabré G, Van Dorpe J, et al. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient. Am J Transplant. 2008; 8: 877-880. Doi :10.1111/j.1600-6143. 2007. 02140. x

: Epaulard O, Saint-Raymond C, Villier C, et al. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbilol Infect. 2010; 16(9): 1362-1364 Doi: 10.1111/j.1469-0691.2009.03124.x

: Wojenski DJ, Bartoo GT, Merten JA, et al. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2015; 17(2): 250-258. Doi: 10.1111/tid.12367.

: Vadnerkar A, Nguyen MH, Mitsani D, et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant. 2010; 29: 1240-1244. Doi: 10.1016/j.healun.2010.05.022.

: Wingard JR, Carter SL, Walsh TJ, et al. Randomised, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood.2010;116:5111-5118 Doi: 10.1182/blood-2010-02-268151.

: Levine DE, Karia PS, Schumults CD. Outcomes of patients with multiple cutaneous squamous cell carcinomas: A 10-Year Single-Institution Cohort Study. JAMA Dermatol.2015;151(11):1220-1225 Doi: 10.1001/jamadermatol.2015.1702.

: Gmeinhart B, Hinterberger W, Greinix HT, et al.Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23(11):1197-1199 Doi: 10.1038/sj.bmt.1701772

: Connnolly K, Manders P, Earls P, Epstein RJ. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. Cancer Treat Rev. 2014; 40(2): 205-214 Doi: 10.1016/j.ctrv.2013.08.005.

: Meyer T, Arndt R, Nindl I, et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int. 2003;16(3):146-153

Doi: 10.1007/s00147-002-0525-7

: Jiyad Z, Olsen CM, Burke MT, et al. Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant 2016; 16: 3490-3503 Doi: 10.1111/ajt.13863.

: O’Neil JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 1186-1191 Doi: 10.1016/j.healun.2006.06.010

: Coghill AE, Johnson LG, Berg D, et al. Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the Skin cancer after Organ Transplant (SCOT) cohort. Am J Transplant 2016; 16: 565-573 Doi: 10.1111/ajt.13596.

: Furukawa F, Fujii K, Horiguchi Y, et al. Roles of E- and P-cadherin in the human skin. Microsc Res Tech 1997; 38: 343-352 Doi: 10.1002/(SICI)1097-0029(19970815)38:4<343::AID-JEMT2>3.0.CO;2-K

: Ingvar Å, Ekström Smedby K, Lindelöf B, et al. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients. Acta Derm Venereol 2012; 92(6): 609-614 Doi: 10.2340/00015555-1271.




DOI: http://dx.doi.org/10.24294/ti.v2.i4.1079

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Yuka Hirakawa, Aika Okuno, Atsuko Tanabe, Mutsumi Okada, Naoyuki Anzai, Yuki Yamamoto, Fukumi Furukawa

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License

This site is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.